Relapse-free survival in different risk groups according to CRAC
Treatment groups . | Total no. . | No. censored . | No. of events (=relapse) . | Relapse-free survival, mo . | SE . | CI . | P . |
|---|---|---|---|---|---|---|---|
| All | |||||||
| CRAC positive | 35 | 32 | 3 | 83.7 | 3.9 | 76.1-91.4 | .019 |
| CRAC negative | 43 | 29 | 14 | 65.8 | 7.0 | 52.0-79.6 | |
| SR | |||||||
| CRAC positive | 14 | 14 | 0 | — | — | — | — |
| CRAC negative | 12 | 11 | 1 | 45.8 | 0.3 | 45.2-46.4 | |
| MR | |||||||
| CRAC positive | 17 | 15 | 2 | 81.4 | 6.3 | 69.0-93.7 | .109 |
| CRAC negative | 18 | 11 | 7 | 61.1 | 8.7 | 44.0-78.2 | |
| HR | |||||||
| CRAC positive | 4 | 3 | 1 | 36.7 | 2.5 | 31.8-41.6 | .388 |
| CRAC negative | 13 | 7 | 6 | 56.3 | 12.2 | 32.3-80.3 |
Treatment groups . | Total no. . | No. censored . | No. of events (=relapse) . | Relapse-free survival, mo . | SE . | CI . | P . |
|---|---|---|---|---|---|---|---|
| All | |||||||
| CRAC positive | 35 | 32 | 3 | 83.7 | 3.9 | 76.1-91.4 | .019 |
| CRAC negative | 43 | 29 | 14 | 65.8 | 7.0 | 52.0-79.6 | |
| SR | |||||||
| CRAC positive | 14 | 14 | 0 | — | — | — | — |
| CRAC negative | 12 | 11 | 1 | 45.8 | 0.3 | 45.2-46.4 | |
| MR | |||||||
| CRAC positive | 17 | 15 | 2 | 81.4 | 6.3 | 69.0-93.7 | .109 |
| CRAC negative | 18 | 11 | 7 | 61.1 | 8.7 | 44.0-78.2 | |
| HR | |||||||
| CRAC positive | 4 | 3 | 1 | 36.7 | 2.5 | 31.8-41.6 | .388 |
| CRAC negative | 13 | 7 | 6 | 56.3 | 12.2 | 32.3-80.3 |
SE indicates standard error; CI, confidence interval; P, significance by log-rank test; SR, standard risk, MR, medium risk, and HR, high-risk treatment groups according to ALL-BFM criteria; and —, not applicable.